Skip to main content
SpringerLink
Log in

Ocular toxicity of multiple intravitreal DHPG injections

  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Intravitreal 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (DHPG) has been advocated as an alternative mode of therapy in cytomegalovirus (CMV) retinitis in the acquired immunodeficiency syndrome (AIDS) because of toxic neutropenia which is a complication of systemic intravenous DHPG [7]. The recommended regimen requires injection of 200 \gmg DHPG intravitreally twice a week for a period of several weeks to months to control the progression of CMV retinitis [5, 14]. A previous study performed to determine the safe dose of intravitreal DHPG was based on a single intravitreal dose study [101; it does not consider the toxicity which may arise from multiple intravitreal injections of DHPG as it is utilized in the treatment of patients with CMV retinitis. In our study, intravitreal injections of 1000, 400, 200, 100, 50, and 25 \gmg DHPG were administered weekly for a period of 5 weeks in rabbit eyes. Ocular toxicity was monitored using slit-lamp biomicroscopy, indirect ophthalmoscopy, electroretinography, and light and electron microscopy. Electroretinographic evidence of retinal toxicity was found with doses as low as 100 \gmg. Electron-micrographic studies of retinal tissue from the eyes injected with even lower doses (as low as 25 \gmg) also showed evidence of toxic vacuolization in the inner segments of the photoreceptor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Diamond JG (1981) Intraocular management of endophthalmitis. A systematic approach. Arch Ophthalmol 99:96–99

    PubMed  Google Scholar 

  2. Felsenstein D, D'Amico DJ, Hirsch MS, Neumeyer DA, Cederberg DM, de Miranda P, Schooley RT (1985) Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethy-1)ethoxymethyl]guanine. Ann Internal Med 103:377–380

    Google Scholar 

  3. Forester RK, Abbott RL, Gelender H (1980) Management of infectious endophthalmitis. Ophthalmology 87:313–318

    PubMed  Google Scholar 

  4. Freeman WR, Lerner CW, Mines JA, Lash RS, Nadel AJ, Starr MB, Tapper ML (1984) A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome. Am J Ophthalmol 97:133–142

    PubMed  Google Scholar 

  5. Henry K, Cantrill HL, Fletcher C, Chinnock BJ, Balfour HH Jr (1987) Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am J Ophthalmol 103:17–23

    PubMed  Google Scholar 

  6. Mar EC, Cheng YC, Huang ES (1983) Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro. Antimicrob Agents Chemother 24:518–521

    PubMed  Google Scholar 

  7. Masur H, Lane HC, Palestine A, Smith PD, Manischewitz J, Stevens G, Fujikawa L, Macher AM, Nussenblatt R, Baird B, Megill M, Wittek A, Quitman GV, Parrillo JE, Rook AH, Eron LJ, Poretz DM, Goldenberg RI, Fauci AS, Gelmann EP (1986) Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men. Ann Internal Med 104:41–44

    Google Scholar 

  8. Palestine AG, Rodrigues MM, Macher AM, Chan CC, Lane HC, Fauci AS, Masur H, Longo D, Reichert CM, Steis R, Rook AH, Nussenblatt RB (1984) Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology 91:1092–1099

    PubMed  Google Scholar 

  9. Pepose IS, Holland GN, Nestor MS, Cochran AJ, Foos RY (1985) Acquired immune deficiency syndrome: pathogenic mechanisms of ocular disease. Ophthalmology 92:472–484

    PubMed  Google Scholar 

  10. Pulido J, Peyman GA, Lesar T, Vernot J (1985) Intravitreal toxicity of hydroxyacyclovir (BW-B759U), a new antiviral agent. Arch Ophthalmol 103:840–841

    PubMed  Google Scholar 

  11. Pulido JS, Palacio M, Peyman GA, Fisiella R, Greenberg D, Stelmack T (1984) Toxicity of intravitreal antiviral drugs. Ophthalmic Surg 15:666–669

    PubMed  Google Scholar 

  12. Rasmussen L, Chen PT, Mullenax JG, Merigan TC (1984) Inhibition of human cytomegalovirus replication by 9-(1,3-dihydroxy-2-propoxymethyl)guanine alone and in combination with human interferons. Antimicrob Agents Chemother 26:441–445

    PubMed  Google Scholar 

  13. Schulman J, Peyman GA, Horton MB, Liu J, Fiscella R, Pulido J, Barber JC, de Miranda P (1986) Intraocular 9-([2-hydroxy-1(hydroxymethyl)ethoxy]methyl)guanine levels after intravitreal and subconjunctival administration. Ophthalmic Surg 17:429–432

    PubMed  Google Scholar 

  14. Ussery FM, Gibson SR, Conklin RH, Piot DF, Stool EW, Conklin AJ (1988) Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis. Ophthalmology 95:640–648

    PubMed  Google Scholar 

  15. Yoshizumi M, Banihashemi A, O'Neal K (1987) Combined amphotericin B and 5-fluorocytosine intravitreal injections. Acta XXV Concilium Ophthalmologicum. Proceedings of the XXVth International Congress of Ophthalmology, Rome. Kugler and Ghedini, Amsterdam Berkeley Milano

    Google Scholar 

  16. Yoshizumi M, Niizawa J, Meyers-Elliott R (1986) Ocular toxicity of intravitreal vidarabine solubilized in dimethyl sulfoxide. Arch Ophthalmol 104:426–430

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jules Stein Eye Institute, Retina Division, UCLA School of Medicine, 200 Stein Plaza, 90024-7007, Los Angeles, CA, USA

    Marc O. Yoshizumi, David Lee & Samantha Fajardo

  2. Ospedale Oftalmico, Torino, Italy

    Virginia Vinci

Authors
  1. Marc O. Yoshizumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Virginia Vinci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Samantha Fajardo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoshizumi, M.O., Lee, D., Vinci, V. et al. Ocular toxicity of multiple intravitreal DHPG injections. Graefe's Arch Clin Exp Ophthalmol 228, 350–355 (1990). https://doi.org/10.1007/BF00920061

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00920061

Keywords

Search

Navigation